Rise Therapeutics Reports UC Dose Escalation Results at DDW Conf
07 Apr 2025 //
PR NEWSWIRE
Rise Therapeutics Gets FDA IND Clearance For R-5780 Cancer Testing
13 Jan 2025 //
PR NEWSWIRE
Dose Escalation done for Rise Therapeutic R-3750 & R-2487 Trials
06 Jan 2025 //
PR NEWSWIRE
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
01 Jul 2024 //
BUSINESSWIRE
First Patient Enrolled in Rise Therapeutics` Rheumatoid Arthritis Clinical Trial
29 Jan 2024 //
PR NEWSWIRE
FDA Clears Rise`s IND Application to Initiate a Phase 1 Study of Immunotherapy
19 Oct 2023 //
PR NEWSWIRE